Synthetic biology and microbioreactor platforms for programmable production of biologics at the point-of-care
Current biopharmaceutical manufacturing platforms use single biologic-producing cell lines cultured at large scales. Here the authors develop a small-scale, portable biomanufacturing platform to produce single dose IFNa2b and rHGH from a single engineered strain of P. pastoris.
Guardado en:
Autores principales: | Pablo Perez-Pinera, Ningren Han, Sara Cleto, Jicong Cao, Oliver Purcell, Kartik A. Shah, Kevin Lee, Rajeev Ram, Timothy K. Lu |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2016
|
Materias: | |
Acceso en línea: | https://doaj.org/article/7d4eb34812f54fcf8365ae570daf603d |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Versatile and on-demand biologics co-production in yeast
por: Jicong Cao, et al.
Publicado: (2018) - Synthetic biology
-
Synthetic Biology: opportunities for Chilean bioindustry and education
por: Federici,Fernán, et al.
Publicado: (2013) -
Synthetic biology beyond borders
por: Karthik Raman, et al.
Publicado: (2021) -
A low-cost paper-based synthetic biology platform for analyzing gut microbiota and host biomarkers
por: Melissa K. Takahashi, et al.
Publicado: (2018)